Prothena Corp Public Ltd Co (PRTA) stock
PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3022% below fair value
$8.35+0.09 (+1.09%)
Close on Nov 18, 2026Market cap $428.66MP/E –Yield –
Prothena Corp Public price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Prothena Corp Public's price to sales ratio was 8.3× on Nov 11, 2026, against 49.1× a year earlier. Over the last 5 years it ranged from 1.8× to 66.1×, with a median of 11.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 8.3× | −35.3 |
| 2025 | Dec 31, 2025 | 43.6× | +38.0 |
| 2024 | Dec 31, 2024 | 5.6× | −8.2 |
| 2023 | Dec 29, 2023 | 13.8× | −6.3 |
| 2022 | Oct 31, 2022 | 20.1× | +8.6 |
| 2021 | Dec 31, 2021 | 11.5× | −441.2 |
| 2019 | Oct 31, 2019 | 452.7× | +37.9 |
| 2018 | Dec 31, 2018 | 414.7× | +362.3 |
| 2017 | Dec 29, 2017 | 52.5× | −318.1 |
| 2016 | Jan 29, 2016 | 370.6× | +0.7 |
| 2015 | Oct 30, 2015 | 369.9× | +358.3 |
| 2014 | Dec 31, 2014 | 11.6× | – |
See a number that looks wrong?